about
The epidemiology of sepsis: questioning our understanding of the role of race.Rising Billing for Intermediate Intensive Care among Hospitalized Medicare Beneficiaries between 1996 and 2010Association of Intensive Care Unit Admission With Mortality Among Older Patients With PneumoniaAssociation Between Noninvasive Ventilation and Mortality Among Older Patients With Pneumonia.ICU Use and Quality of Care for Patients With Myocardial Infarction and Heart Failure.Intensive Care Unit Admission and Mortality Among Medicare Beneficiaries With Pneumonia--Reply.Disruptive Technology. Can Electronic Portals Promote Communication in the Intensive Care Unit?Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: a report of three cases.ICU team composition and its association with ABCDE implementation in a quality collaborative.Dysphagia dietary guidelines and the rheology of nutritional feeds and barium test feeds.Intensive Care Unit Admission and Survival among Older Patients with Chronic Obstructive Pulmonary Disease, Heart Failure, or Myocardial Infarction.Appraising the Evidence Supporting Choosing Wisely® Recommendations.Estimating ICU Benefit: A Randomized Study of PhysiciansThe Search for the Optimal Intensive Care Unit Triage ModelPrior Vaccination and Effectiveness of Communication Strategies Used to Describe Infectious DiseasesElectronic "Sniffer" Systems to Identify the Acute Respiratory Distress SyndromeTrends in Hospital Utilization After Medicaid ExpansionExplaining the Process of Determining Futility Increases Lay Public AcceptanceRegional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United StatesIntensive care use and mortality among patients with ST elevation myocardial infarction: retrospective cohort studyICU beds: less is more? YesThe authors replyValidating a Widely Implemented Deterioration Index Model Among Hospitalized COVID-19 Patients
P50
Q36110121-B4632DB5-BF24-4249-9F25-05C1538B9C7EQ36516868-CACC991E-2DED-4708-88AA-1E038C36AF28Q36592295-B3552B98-317A-498D-A690-5CA0906B92E5Q38810783-C52B8E39-5739-47B2-836F-289F2902A67BQ39673273-9127E8C9-7791-4C07-BFE7-72FEEA8B15F5Q42368281-86DB072B-27D6-45CF-903B-ED50D58763AFQ42397004-A329EFEA-954D-481B-8B4D-1EE003104FC5Q44541129-16557A65-59D6-4F96-B94E-2FA8BC6BA0B1Q47753581-705BAA6E-AADB-4A70-A69F-5470131B0D38Q47846417-E21CD83F-A293-42C1-A66F-3CC1F981BBDBQ47967566-EA6D293B-C14B-4E34-A591-1F66A22CBC6CQ52563690-CE0AF497-402B-4B52-933D-6D5FF7376AA1Q57288304-16CF2BD8-3453-4E36-A0A9-B10BD29716FDQ58078243-4BE3BF9A-1805-483E-B7B1-B078AE5219D5Q64091624-5A28798E-4396-4F68-BBDB-BFFEBF157238Q90308395-4D6F913E-DC46-42CB-9586-5472AF10728AQ91574201-97D67863-090A-46CA-8891-DBB28F92C139Q91793809-7FE2DF72-5033-4A26-A268-18DAB9F547B5Q92009311-67182C4C-1DEB-441D-A154-288BDA7EAD43Q92523445-1DA9F9DB-7E8A-4844-8720-D99903644C22Q93232101-B31D08B2-08F3-47A3-8AB2-DD1409291034Q94352965-7630928B-4668-4DCB-B471-C4D44D5D9231Q95627021-0D4258EA-4318-48A0-89A8-63AD24BC0A1D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Thomas S. Valley
@ast
Thomas S. Valley
@en
Thomas S. Valley
@es
Thomas S. Valley
@nl
Thomas S. Valley
@sl
type
label
Thomas S. Valley
@ast
Thomas S. Valley
@en
Thomas S. Valley
@es
Thomas S. Valley
@nl
Thomas S. Valley
@sl
altLabel
Tom Valley
@en
prefLabel
Thomas S. Valley
@ast
Thomas S. Valley
@en
Thomas S. Valley
@es
Thomas S. Valley
@nl
Thomas S. Valley
@sl
P106
P1153
54386099800
P21
P31
P496
0000-0002-5766-4970